TW200626080A - Food compositions comprising valine for improving lipid metabolism - Google Patents
Food compositions comprising valine for improving lipid metabolismInfo
- Publication number
- TW200626080A TW200626080A TW095109909A TW95109909A TW200626080A TW 200626080 A TW200626080 A TW 200626080A TW 095109909 A TW095109909 A TW 095109909A TW 95109909 A TW95109909 A TW 95109909A TW 200626080 A TW200626080 A TW 200626080A
- Authority
- TW
- Taiwan
- Prior art keywords
- lipid metabolism
- improving lipid
- valine
- compositions
- food compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 235000013305 food Nutrition 0.000 title abstract 3
- 230000037356 lipid metabolism Effects 0.000 title abstract 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 title abstract 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 title abstract 2
- 239000004474 valine Substances 0.000 title abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 3
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 3
- 235000020824 obesity Nutrition 0.000 abstract 3
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000312862 | 2000-10-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200626080A true TW200626080A (en) | 2006-08-01 |
Family
ID=18792372
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW090125293A TWI266614B (en) | 2000-10-13 | 2001-10-12 | Compositions comprising valine for improving lipid metabolism |
TW095109909A TW200626080A (en) | 2000-10-13 | 2001-10-12 | Food compositions comprising valine for improving lipid metabolism |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW090125293A TWI266614B (en) | 2000-10-13 | 2001-10-12 | Compositions comprising valine for improving lipid metabolism |
Country Status (10)
Country | Link |
---|---|
US (1) | US7238727B2 (zh) |
EP (1) | EP1325743A4 (zh) |
JP (1) | JPWO2002030418A1 (zh) |
KR (1) | KR20030036898A (zh) |
CN (1) | CN1278677C (zh) |
AU (2) | AU2001294245B2 (zh) |
CA (1) | CA2425773A1 (zh) |
HK (1) | HK1059052A1 (zh) |
TW (2) | TWI266614B (zh) |
WO (1) | WO2002030418A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200518768A (en) * | 2003-11-17 | 2005-06-16 | Pepgen Corp | Methods for treatment of obesity and for promotion of weight loss |
EP1832284A4 (en) * | 2004-12-28 | 2008-07-30 | Ajinomoto Kk | INDUCER OR SECRETAGOGUE OF ADIPONECTIN |
WO2007049818A1 (ja) * | 2005-10-27 | 2007-05-03 | Ajinomoto Co., Inc. | 抗脂肪肝、抗肥満及び抗高脂血症用組成物 |
WO2007069744A1 (ja) * | 2005-12-16 | 2007-06-21 | Ajinomoto Co., Inc. | メタボリックシンドローム予防・改善用組成物 |
PT2440232T (pt) * | 2009-06-12 | 2018-03-23 | Wisconsin Alumni Res Found | Formulações nutricionais à base de glicomacropeptídeo para o tratamento dietético da fenilcetonúria e de outras doenças metabólicas |
EP2741757B1 (en) | 2011-09-11 | 2018-05-16 | Minovia Therapeutics Ltd. | Compositions of functional mitochondria and uses thereof |
CN107296264A (zh) * | 2016-04-14 | 2017-10-27 | 高安友 | 预防及治疗高血脂、脂肪肝的大鲵油脂食品及其制备方法 |
JP7458368B2 (ja) | 2018-07-22 | 2024-03-29 | ミノヴィア セラピューティクス リミテッド | 筋疾患のミトコンドリア増強療法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4042687A (en) * | 1975-11-24 | 1977-08-16 | Control Drug, Inc. | Method of treating obesity by the oral administration of a predigested protein composition |
US4833128A (en) * | 1984-12-28 | 1989-05-23 | Neil Solomon | Dietary supplement |
WO1988001872A1 (en) * | 1986-09-10 | 1988-03-24 | Dudrick Medical Research Fund I, Ltd. | Method and substrate composition for treating atherosclerosis |
US5032608A (en) * | 1986-09-10 | 1991-07-16 | Dudrick Stanley J | Method and substrate composition for treating atherosclerosis |
US4920098A (en) * | 1986-09-17 | 1990-04-24 | Baxter International Inc. | Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases |
US5132113A (en) | 1990-10-26 | 1992-07-21 | Maurizio Luca | Nutritional composition containing essential amino acids |
US5242697A (en) * | 1990-10-26 | 1993-09-07 | Maurizio Luca | Method of preparing nutrified food products |
AU655780B2 (en) | 1990-10-30 | 1995-01-12 | Clintec Nutrition Company | A method and composition for the protection of a metabolic recovery of ischemic cardiac tissue |
EP0605742A4 (en) | 1992-06-26 | 1996-01-03 | Nonna Dmitrievna Kislyakova | Agent with adaptogenic activity. |
JPH0624977A (ja) * | 1992-07-10 | 1994-02-01 | Rikagaku Kenkyusho | 抗肥満剤及び抗高脂血症剤 |
JP4009682B2 (ja) * | 1993-05-28 | 2007-11-21 | 独立行政法人理化学研究所 | アドレナリン及びノルアドレナリン分泌促進組成物 |
IT1274783B (it) | 1994-12-15 | 1997-07-24 | Antonio Picarelli | Preparato per il trattamento dell'obesita' |
DE19528388A1 (de) | 1995-08-02 | 1997-02-06 | Hans Peter Prof Dr Med Zenner | Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs |
JP4484254B2 (ja) * | 1995-12-06 | 2010-06-16 | 佐々木化学工業株式会社 | アミノ酸組成剤 |
WO1997025883A1 (de) | 1996-01-17 | 1997-07-24 | Friedrich Kisters | Aminosäuren-präparat zur haarwuchsförderung |
TW473387B (en) | 1997-09-30 | 2002-01-21 | Chugai Pharmaceutical Co Ltd | Pharmaceutical or food compositions for treating hepatic diseases or improving liver functions |
US6149924A (en) | 1998-07-20 | 2000-11-21 | Biomed Research & Technologies, Inc. | Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin |
-
2001
- 2001-10-12 EP EP01974826A patent/EP1325743A4/en not_active Withdrawn
- 2001-10-12 CN CNB018172563A patent/CN1278677C/zh not_active Expired - Fee Related
- 2001-10-12 JP JP2002533859A patent/JPWO2002030418A1/ja not_active Withdrawn
- 2001-10-12 TW TW090125293A patent/TWI266614B/zh not_active IP Right Cessation
- 2001-10-12 AU AU2001294245A patent/AU2001294245B2/en not_active Ceased
- 2001-10-12 AU AU9424501A patent/AU9424501A/xx active Pending
- 2001-10-12 WO PCT/JP2001/008991 patent/WO2002030418A1/ja active Application Filing
- 2001-10-12 CA CA002425773A patent/CA2425773A1/en not_active Abandoned
- 2001-10-12 US US10/399,145 patent/US7238727B2/en not_active Expired - Fee Related
- 2001-10-12 KR KR10-2003-7004948A patent/KR20030036898A/ko active IP Right Grant
- 2001-10-12 TW TW095109909A patent/TW200626080A/zh unknown
-
2004
- 2004-03-20 HK HK04102054A patent/HK1059052A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TWI266614B (en) | 2006-11-21 |
WO2002030418A1 (fr) | 2002-04-18 |
AU2001294245B2 (en) | 2006-09-21 |
US7238727B2 (en) | 2007-07-03 |
JPWO2002030418A1 (ja) | 2004-02-19 |
KR20030036898A (ko) | 2003-05-09 |
CN1469740A (zh) | 2004-01-21 |
US20030183091A1 (en) | 2003-10-02 |
HK1059052A1 (en) | 2004-06-18 |
AU9424501A (en) | 2002-04-22 |
CA2425773A1 (en) | 2003-04-11 |
EP1325743A4 (en) | 2004-12-15 |
CN1278677C (zh) | 2006-10-11 |
EP1325743A1 (en) | 2003-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL368976A1 (en) | Composition for lowering blood cholesterol | |
HK1034647A1 (en) | Product and method to reduce stress induced immunesuppression. | |
AU2002256093A1 (en) | Bulking agents as satiety agents | |
AR020345A1 (es) | Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones. | |
SG150510A1 (en) | Lipase activity inhibitors containing high-molecular weight polyphenol fractions, tea extracts, and processes for producing the same | |
EP1582207A4 (en) | HEMMER FOR OUTBREAKING AND PROGREDIENCE OF LIVER CANCER | |
MY130670A (en) | 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines | |
CA2290072A1 (en) | Citrus products incorporating pulp processing | |
HK1074592A1 (en) | 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
WO2007022344A3 (en) | Methods and compositions for the preventioin and treatment of kidney disease | |
GT199900035A (es) | Producto de higiene personal con despacho aumentado de fragancia. | |
BG109876A (en) | APPLICATION OF L-CARNITIN ESTERS OR ALCANAILIC L-CARNITINES AS CATIONARY LIPIDS FOR INTRACULAR TRANSMISSION OF PHARMACOLOGICALLY ACTIVE SUBSTANCES | |
AU4073901A (en) | Novel pharmaceutical or dietetic mushroom-based compositions | |
EP0841065A3 (en) | Use of sericin as antioxidants and tyrosinase inhibitors | |
WO1999066914A3 (en) | Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-l-carnitine and hypericin | |
TW200626080A (en) | Food compositions comprising valine for improving lipid metabolism | |
HK1083296A1 (en) | Enteral composition for the prevention and/or treatment of sepsis | |
MX2007004879A (es) | Proteccion de ingredientes de alimentos bioactivos por medio de encapsulacion. | |
MXPA04001129A (es) | Mezclas de lipidos y productos de alimento que contienen acido graso oleico y acidos grasos omega-6, disenadas para incrementar el nivel intramiocelular de lipidos. | |
WO2000043036A3 (en) | Lipoprotein complexes and compositions containing them | |
SI1708711T1 (sl) | Spojine uporabne posebno za zdravljenje ali prepreäśevanje metaboliäśnega sindroma | |
MY130792A (en) | 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES | |
WO2006093408A3 (en) | Bacteria that naturally overproduce folate | |
WO2006089211A3 (en) | Combat/training antioxidant micronutrient formulation and method of administration | |
AU2002222589A1 (en) | Oral preprations having itching-relievign or antipruritic activity |